Prospective HIV RNA screening with long-acting cabotegravir pre-exposure prophylaxis in HPTN 083

By afschroeder • April 28, 2026

Landovitz RJ, Fogel JM, Gao F, Hanscom B, Piwowar-Manning E, Moser A, Marzinke MA, Cyktor J, Seisa M, Halvas EK, Kofron R, Jennings A, Clement M, Viet Tran H, Gaur A, Fichtenbaum CJ, Asmelash A, Soto-Torres L, Rooney JF, Rinehart AR, Cohen MS, Grinsztejn B, Eshleman SH. Prospective HIV RNA screening with long-acting cabotegravir pre-exposure prophylaxis in HPTN 083. Clin Infect Dis. 2026 Apr 27:ciag285. doi: 10.1093/cid/ciag285. Epub ahead of print. PMID: 42044061.

Tags: Cabotegravir, Diagnosis, HIV, Infectious Diseases, injectable, Pre-exposure prophylaxis, Publications, RNA

Effect of inhaled interferon-β1a on SARS-CoV-2 diversity and evolution

Edelstein GE, Sass TN, Deo R, Glover OT, Boucau J, Jaganathan P, Chew KW, Giganti MJ, Hughes MD, Moser C, Javan AC, Fletcher CV, McCarthy[...]

Assessing mpox knowledge and sexual behaviours within high-risk populations in the Democratic Republic of the Congo

Lemaille C, Halbrook M, Merritt S, Anta Y, Lunyanga L, Mukadi PK, Hasivirwe Vakaniaki E, Kalonji T, Kenye M, Kacita C, Linsuke S, Bogoch II,[...]

β-Glucan chitosan particle provides cross-protection against multi-drug-resistant Candida auris

Singh S, Barbarino A, Youssef EG, Das Gupta K, Nabeela S, Gebremariam T, Alkhazraji S, Uppuluri P, Ostroff G, Ibrahim AS. β-Glucan chitosan particle provides[...]